Form 13-F position report

BIOANALYTICAL SYSTEMS INC

Reported by BRIDGEWAY CAPITAL MANAGEMENT LLC

NOTV CUSIP 09058M103 Manager CIK 0001107261

Reported 0 shares, down 67,510 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q1 2021
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 16 Through Q1 2021

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value

Quarterly position history

How this manager's reported quarter-end position changed over time.

0 quarters
Quarterly reported position history for BIOANALYTICAL SYSTEMS INC held by BRIDGEWAY CAPITAL MANAGEMENT LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
This position's reported history falls outside the five-year preview window. A free account unlocks it. Unlock full history

Who else reported the position

18 managers reported BIOANALYTICAL SYSTEMS INC for Q1 2021.

Managers reporting BIOANALYTICAL SYSTEMS INC in Q1 2021.
Manager Activity Shares Change % of reported 13F Reported value Tenure
EAM Investors LLC Reduced 0 -21,958 0 $0 2 qtrs
Versant Capital Management Inc Reduced 0 -19,191 0 $0 14 qtrs
BRIDGEWAY CAPITAL MANAGEMENT LLC This report Reduced 0 -67,510 0 $0 16 qtrs
O SHAUGHNESSY ASSET MANAGEMENT LLC Reduced 0 -130 0 $0 2 qtrs
Virtu Financial LLC Reduced 0 -10,089 0 $0 2 qtrs
NORTHERN TRUST CORPORATION Reduced 0 -10,401 0 $0 3 qtrs
IFP Advisors Inc Unchanged 0 0 0 $0 7 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 11 qtrs
ISZO CAPITAL MANAGEMENT LP Reduced 0 -760,015 0 $0 2 qtrs
NEXT CENTURY GROWTH INVESTORS LLC Reduced 0 -43,458 0 $0 2 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
March 31, 2021
Filed
May 17, 2021
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.